128 related articles for article (PubMed ID: 3568423)
1. Serum pepsinogens I and II and stomach cancer.
Stemmermann GN; Samloff IM; Nomura AM; Heilbrun LK
Clin Chim Acta; 1987 Mar; 163(2):191-8. PubMed ID: 3568423
[TBL] [Abstract][Full Text] [Related]
2. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
[TBL] [Abstract][Full Text] [Related]
4. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.
Miki K; Ichinose M; Kawamura N; Matsushima M; Ahmad HB; Kimura M; Sano J; Tashiro T; Kakei N; Oka H
Jpn J Cancer Res; 1989 Feb; 80(2):111-4. PubMed ID: 2498245
[TBL] [Abstract][Full Text] [Related]
5. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
You WC; Blot WJ; Zhang L; Kneller RW; Li JY; Jin ML; Chang YS; Zeng XR; Zhao L; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):113-7. PubMed ID: 8467245
[TBL] [Abstract][Full Text] [Related]
6. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
7. Serum pepsinogens as a screening test of extensive chronic gastritis.
Miki K; Ichinose M; Shimizu A; Huang SC; Oka H; Furihata C; Matsushima T; Takahashi K
Gastroenterol Jpn; 1987 Apr; 22(2):133-41. PubMed ID: 3596151
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
9. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
10. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.
Urita Y; Hike K; Torii N; Kikuchi Y; Kanda E; Sasajima M; Miki K
Dig Dis Sci; 2004 May; 49(5):795-801. PubMed ID: 15259501
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area.
Gantuya B; Oyuntsetseg K; Bolor D; Erdene-Ochir Y; Sanduijav R; Davaadorj D; Tserentogtokh T; Uchida T; Yamaoka Y
Gastric Cancer; 2019 Jan; 22(1):104-112. PubMed ID: 29934751
[TBL] [Abstract][Full Text] [Related]
12. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
13. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
17. [Serum pepsinogen I level in patients with stomach cancer--its value and limitation in clinical use].
Miki K; Ichinose M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1122-8. PubMed ID: 2730017
[TBL] [Abstract][Full Text] [Related]
18. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
19. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
Westerveld BD; Pals G; Lamers CB; Defize J; Pronk JC; Frants RR; Ooms EC; Kreuning J; Kostense PJ; Eriksson AW
Cancer; 1987 Mar; 59(5):952-8. PubMed ID: 3815274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
